ProQR Therapeutics (PRQR) Earnings Date, Estimates & Call Transcripts → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free PRQR Stock Alerts $1.94 0.00 (-0.01%) (As of 02:57 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (Mar. 13) -$0.08 Consensus EPS (Mar. 13) -$0.08 Get ProQR Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for PRQR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePRQR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PRQR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report ProQR Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($0.12)($0.12)($0.12)PRQR Earnings Date and InformationProQR Therapeutics last issued its earnings results on March 13th, 2024. The biopharmaceutical company reported ($0.08) earnings per share for the quarter, meeting the consensus estimate of ($0.08). The business had revenue of $3.54 million for the quarter, compared to analyst estimates of $27.88 million. ProQR Therapeutics has generated ($0.37) earnings per share over the last year (($0.37) diluted earnings per share). Earnings for ProQR Therapeutics are expected to decrease in the coming year, from ($0.37) to ($0.47) per share. ProQR Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More ProQR Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 3/13/2024Q4 2023($0.08)($0.08)-($0.08)$27.88 million$3.54 million11/7/2023Q3 2023($0.06)($0.08)($0.02)($0.08)$8.63 million$1.49 million8/3/2023Q2 2023($0.12)($0.11)+$0.01($0.11)$2.77 million$1.31 million5/16/2023Q1 2023($0.12)($0.12)-($0.12)$2.87 million$0.70 million3/29/2023Q4 2022($0.20)($0.16)+$0.04($0.16)$1.00 million$0.84 million11/9/2022Q3 2022($0.23)($0.34)($0.11)($0.34)$1.05 million$0.96 million Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.26)($0.22)+$0.04($0.22)$1.21 million$1.09 million5/5/2022Q1 2022($0.25)($0.22)+$0.03($0.22)$1.19 million$1.39 million2/24/2022Q4 2021($0.26)($0.30)($0.04)($0.30)$0.90 million$0.27 million 11/4/2021Q3 2021($0.21)($0.22)($0.01)($0.26)$0.80 million$1.03 million8/5/2021Q2 2021($0.21)($0.24)($0.03)($0.29)$0.80 million$0.29 million ProQR Therapeutics Earnings - Frequently Asked Questions When is ProQR Therapeutics's earnings date? ProQR Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on PRQR's earnings history. Did ProQR Therapeutics beat their earnings estimates last quarter? In the previous quarter, ProQR Therapeutics (NASDAQ:PRQR) reported ($0.08) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.08). Learn more on analysts' earnings estimate vs. PRQR's actual earnings. How much revenue does ProQR Therapeutics generate each year? ProQR Therapeutics (NASDAQ:PRQR) has a recorded annual revenue of $10.31 million. How much profit does ProQR Therapeutics generate each year? ProQR Therapeutics (NASDAQ:PRQR) has a recorded net income of -$30.43 million. PRQR has generated -$0.37 earnings per share over the last four quarters. What is ProQR Therapeutics's EPS forecast for next year? ProQR Therapeutics's earnings are expected to decrease from ($0.37) per share to ($0.47) per share in the next year. More Earnings Resources from MarketBeat Related Companies: GOSS Earnings Date SKYE Earnings Date MCRB Earnings Date PRLD Earnings Date CAPR Earnings Date IXHL Earnings Date CRVO Earnings Date GLSI Earnings Date SCPH Earnings Date INCR Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:PRQR) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProQR Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.